LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 62

Search options

  1. Article ; Online: Methylchloroisothiazolinone and methylisothiazolinone contact allergy: A retrospective cohort study from a tertiary dermatology clinic in Turkey.

    Salman, Andac

    Contact dermatitis

    2018  Volume 80, Issue 3, Page(s) 193–194

    MeSH term(s) Adolescent ; Adult ; Aged ; Child ; Dermatitis, Allergic Contact/etiology ; Disinfectants/adverse effects ; Erythema/chemically induced ; Female ; Humans ; Male ; Middle Aged ; Outpatient Clinics, Hospital ; Patch Tests ; Retrospective Studies ; Tertiary Care Centers ; Thiazoles/adverse effects ; Turkey ; Young Adult
    Chemical Substances Disinfectants ; Thiazoles ; 2-methyl-4-isothiazolin-3-one (229D0E1QFA) ; 5-chloro-2-methyl-4-isothiazolin-3-one (DEL7T5QRPN)
    Language English
    Publishing date 2018-12-13
    Publishing country England
    Document type Journal Article
    ZDB-ID 193121-0
    ISSN 1600-0536 ; 0105-1873
    ISSN (online) 1600-0536
    ISSN 0105-1873
    DOI 10.1111/cod.13175
    Database MEDical Literature Analysis and Retrieval System OnLINE

    Full text online

    More links

    Kategorien

    In stock of ZB MED Cologne/Königswinter

    Zs.A 1116: Show issues Location:
    Je nach Verfügbarkeit (siehe Angabe bei Bestand)
    bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular
    Jg. 1995 - 2021: Lesesall (1.OG)
    ab Jg. 2022: Lesesaal (EG)

    Order via subito

    This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.

  2. Article ; Online: Visual Dermatology: Koebner's Phenomenon Due to Wet Cupping Therapy.

    Gulus-Demirel, Beril / Salman, Andac

    Journal of cutaneous medicine and surgery

    2020  Volume 25, Issue 3, Page(s) 333

    MeSH term(s) Administration, Topical ; Adrenal Cortex Hormones/administration & dosage ; Adult ; Back ; Cupping Therapy/adverse effects ; Diagnosis, Differential ; Humans ; Male ; Skin Diseases/drug therapy ; Skin Diseases/etiology
    Chemical Substances Adrenal Cortex Hormones
    Language English
    Publishing date 2020-06-29
    Publishing country United States
    Document type Case Reports ; Journal Article
    ZDB-ID 1361720-5
    ISSN 1615-7109 ; 1203-4754
    ISSN (online) 1615-7109
    ISSN 1203-4754
    DOI 10.1177/1203475420936654
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

    In stock of ZB MED Cologne/Königswinter

    Zs.A 4987: Show issues Location:
    Je nach Verfügbarkeit (siehe Angabe bei Bestand)
    bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular
    Jg. 1995 - 2021: Lesesall (2.OG)
    ab Jg. 2022: Lesesaal (EG)

    Order via subito

    This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.

  3. Article ; Online: Biomarkers to predict therapeutic response in chronic spontaneous urticaria: a review.

    Gimenez-Arnau, Ana Maria / Salman, Andaç / Podder, Indrashis

    European journal of dermatology : EJD

    2024  Volume 34, Issue 1, Page(s) 3–12

    Abstract: Chronic spontaneous urticaria (CSU) is a relatively common dermatological disorder characterized by sudden and unpredictable onset of pruritic wheals and/or angioedema, for more than six weeks. It is a mast cell-mediated histaminergic disorder, ... ...

    Abstract Chronic spontaneous urticaria (CSU) is a relatively common dermatological disorder characterized by sudden and unpredictable onset of pruritic wheals and/or angioedema, for more than six weeks. It is a mast cell-mediated histaminergic disorder, considerably worsening patients' quality of life. Current treatment options include anti-histamines, omalizumab and cyclosporine, in a step-wise algorithmic approach, aimed at complete symptom control. Patients do not respond uniformly to these therapeutic options due to phenotypic and endotypic heterogeneity, and often remain uncontrolled/poorly controlled. Recent research is focused on identifying certain biomarkers to predict therapeutic response and facilitate patient-targeted personalized treatment, for maximum benefit. The current article summarizes various biomarkers explored to date, and also elaborates their role in predicting therapeutic response to anti-histamines, omalizumab and cyclosporine, in CSU patients. High disease activity, elevated CRP/ESR and elevated D-dimer are the most important predictors of non/poor-response to antihistamines. Low and very low baseline IgE, elevated CRP/ESR, ASST+, BAT/BHRA+, basopenia, eosinopenia, and elevated D-dimer are predictors of poor and good response to omalizumab and cyclosporine, respectively. Additionally, normal or slightly elevated baseline IgE and FceR1 overexpression are predictors of a faster response with omalizumab. However, none of these predictors have so far been completely validated and are not yet recommended for routine use. Thus, large-scale prospective studies are needed to confirm these predictive biomarkers and identify new ones to achieve the goal of personalized medicine for CSU.
    MeSH term(s) Humans ; Omalizumab/therapeutic use ; Quality of Life ; Chronic Disease ; Chronic Urticaria/drug therapy ; Urticaria/drug therapy ; Urticaria/diagnosis ; Histamine Antagonists/therapeutic use ; Biomarkers ; Cyclosporine/therapeutic use ; Immunoglobulin E ; Anti-Allergic Agents/therapeutic use ; Treatment Outcome
    Chemical Substances Omalizumab (2P471X1Z11) ; Histamine Antagonists ; Biomarkers ; Cyclosporine (83HN0GTJ6D) ; Immunoglobulin E (37341-29-0) ; Anti-Allergic Agents
    Language English
    Publishing date 2024-04-01
    Publishing country France
    Document type Review ; Journal Article
    ZDB-ID 1128666-0
    ISSN 1952-4013 ; 1167-1122
    ISSN (online) 1952-4013
    ISSN 1167-1122
    DOI 10.1684/ejd.2024.4600
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

    In stock of ZB MED Cologne/Königswinter

    Zs.A 3484: Show issues Location:
    Je nach Verfügbarkeit (siehe Angabe bei Bestand)
    bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular
    Jg. 1995 - 2021: Lesesall (2.OG)
    ab Jg. 2022: Lesesaal (EG)

    Order via subito

    This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.

  4. Article ; Online: Comment on "Cling film for mobile phones to prevent cross-infection during the COVID-19 pandemic".

    Salman, Andac / Cömert-Özer, Elif / Esen-Salman, Kübra

    Journal of the American Academy of Dermatology

    2020  Volume 84, Issue 1, Page(s) e35–e36

    MeSH term(s) COVID-19 ; Cell Phone ; Humans ; Mass Media ; Pandemics ; SARS-CoV-2
    Keywords covid19
    Language English
    Publishing date 2020-10-01
    Publishing country United States
    Document type Letter ; Comment
    ZDB-ID 603641-7
    ISSN 1097-6787 ; 0190-9622
    ISSN (online) 1097-6787
    ISSN 0190-9622
    DOI 10.1016/j.jaad.2020.09.073
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

    In stock of ZB MED Cologne/Königswinter

    Zs.A 1540: Show issues Location:
    Je nach Verfügbarkeit (siehe Angabe bei Bestand)
    bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular
    Jg. 1995 - 2021: Lesesall (1.OG)
    ab Jg. 2022: Lesesaal (EG)

    Order via subito

    This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.

  5. Article ; Online: Remission of chronic spontaneous urticaria following omalizumab with gradually extended dosing intervals: Real-life data.

    Salman, Andac / Aktas, Meryem / Apti Sengun, Ozlem

    The Australasian journal of dermatology

    2021  Volume 62, Issue 3, Page(s) 398–402

    Abstract: Omalizumab is a well-established treatment option in chronic spontaneous urticaria unresponsive to antihistamines at standard or higher doses. However, characteristics of the remission and relapse following the withdrawal of omalizumab remain largely ... ...

    Abstract Omalizumab is a well-established treatment option in chronic spontaneous urticaria unresponsive to antihistamines at standard or higher doses. However, characteristics of the remission and relapse following the withdrawal of omalizumab remain largely unknown. We aimed to define the characteristics of remission in CSU following omalizumab with gradually lengthened dosing intervals in this retrospective study of 102 patients who were treated with at least 3 doses of omalizumab between 2013 and 2020. Of 102 patients, 70 (68.6%) showed a CR to omalizumab at standard doses. Omalizumab could be discontinued in 47 of 70 patients using gradually lengthened dosing intervals. Following a mean follow-up duration of 12.2 months, 25 (58.1%) patients were still in remission while 18 (41.9%) had relapse (Follow-up data were not available in 4 patients). The relapses were unresponsive to antihistamines in 14 patients (77.7%), however, re-treatment with omalizumab led to complete control of symptoms. The patients younger than 40 were more likely to relapse. Despite the need for comparison with fixed-dosing intervals in larger, prospective studies, the results of this study imply that omalizumab with gradually extended dosing intervals might provide a long duration of remission in CSU.
    MeSH term(s) Adult ; Anti-Allergic Agents/therapeutic use ; Chronic Urticaria/drug therapy ; Dose-Response Relationship, Drug ; Female ; Follow-Up Studies ; Humans ; Male ; Middle Aged ; Omalizumab/therapeutic use ; Retrospective Studies ; Time Factors
    Chemical Substances Anti-Allergic Agents ; Omalizumab (2P471X1Z11)
    Language English
    Publishing date 2021-06-22
    Publishing country Australia
    Document type Journal Article
    ZDB-ID 138052-7
    ISSN 1440-0960 ; 0004-8380
    ISSN (online) 1440-0960
    ISSN 0004-8380
    DOI 10.1111/ajd.13656
    Database MEDical Literature Analysis and Retrieval System OnLINE

    Full text online

    More links

    Kategorien

    In stock of ZB MED Cologne/Königswinter

    Zs.A 236: Show issues Location:
    Je nach Verfügbarkeit (siehe Angabe bei Bestand)
    bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular
    Jg. 1995 - 2021: Lesesall (1.OG)
    ab Jg. 2022: Lesesaal (EG)

    Order via subito

    This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.

  6. Article ; Online: Yellow Urticaria.

    Çakıcı, Özlem Akın / Sengün, Ozlem Apti / Tekin, Selcen Hosgören / Salman, Andac

    The journal of allergy and clinical immunology. In practice

    2020  Volume 9, Issue 1, Page(s) 479–480

    MeSH term(s) Humans ; Urticaria/diagnosis
    Language English
    Publishing date 2020-11-03
    Publishing country United States
    Document type Journal Article
    ZDB-ID 2843237-X
    ISSN 2213-2201 ; 2213-2198
    ISSN (online) 2213-2201
    ISSN 2213-2198
    DOI 10.1016/j.jaip.2020.10.029
    Database MEDical Literature Analysis and Retrieval System OnLINE

    Full text online

    More links

    Kategorien

    In stock of ZB MED Cologne/Königswinter

    Zs.A 7086: Show issues Location:
    Je nach Verfügbarkeit (siehe Angabe bei Bestand)
    bis Jg. 2021: Bestellungen von Artikeln über das Online-Bestellformular
    ab Jg. 2022: Lesesaal (EG)

    Order via subito

    This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.

  7. Article ; Online: The Real-Life Effectiveness and Safety of Omalizumab Updosing in Patients With Chronic Spontaneous Urticaria.

    Salman, Andac / Comert, Elif

    Journal of cutaneous medicine and surgery

    2019  Volume 23, Issue 5, Page(s) 496–500

    Abstract: Background: Omalizumab is a third-line treatment for chronic spontaneous urticaria (CSU). Studies investigating the use of higher doses of omalizumab in patients unresponsive to regular doses are limited.: Objectives: This study aims to investigate ... ...

    Abstract Background: Omalizumab is a third-line treatment for chronic spontaneous urticaria (CSU). Studies investigating the use of higher doses of omalizumab in patients unresponsive to regular doses are limited.
    Objectives: This study aims to investigate the effectiveness and safety of omalizumab 450 mg in CSU.
    Methods: A retrospective cohort study was conducted. The response to therapy was evaluated using the Urticaria Activity Score over 7 days (UAS7) and the Urticaria Control Test (UCT). Patients showing complete response (CR) (UAS7: 0-1) to omalizumab 300 mg (Group 1) and patients receiving at least 3 doses of omalizumab 450 mg (Group 2) between 2016 and 2018 were included.
    Results: A total of 72 patients (Group 1: 59; Group 2: 13) were included. In Group 2, the mean UAS7 score decreased from 18.6 to 5.1 and the mean UCT score increased from 8.6 to 12 after a mean 4.3 courses of 450 mg omalizumab treatment. Of the 13 patients in Group 2, 6 had CR and 3 had good disease control (UAS7: 2-6). The rate of patients with low baseline IgE levels (< 43 IU/mL) was significantly higher in Group 2.
    Conclusions: Higher doses of omalizumab are effective and safe in patients with CSU that is unresponsive to omalizumab 300 mg. Lower baseline total IgE levels might be used as a predictor of nonresponse to omalizumab and the need for higher doses.
    MeSH term(s) Adolescent ; Adult ; Aged ; Aged, 80 and over ; Anti-Allergic Agents/administration & dosage ; Chronic Urticaria/blood ; Chronic Urticaria/drug therapy ; Female ; Humans ; Immunoglobulin E/blood ; Male ; Middle Aged ; Omalizumab/administration & dosage ; Retreatment ; Retrospective Studies ; Severity of Illness Index ; Young Adult
    Chemical Substances Anti-Allergic Agents ; Omalizumab (2P471X1Z11) ; Immunoglobulin E (37341-29-0)
    Language English
    Publishing date 2019-04-29
    Publishing country United States
    Document type Journal Article
    ZDB-ID 1361720-5
    ISSN 1615-7109 ; 1203-4754
    ISSN (online) 1615-7109
    ISSN 1203-4754
    DOI 10.1177/1203475419847956
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

    In stock of ZB MED Cologne/Königswinter

    Zs.A 4987: Show issues Location:
    Je nach Verfügbarkeit (siehe Angabe bei Bestand)
    bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular
    Jg. 1995 - 2021: Lesesall (2.OG)
    ab Jg. 2022: Lesesaal (EG)

    Order via subito

    This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.

  8. Article ; Online: Autoimmun-Progesteron-Dermatitis, die ein fixes Arzneimittelexanthem vortäuscht.

    Salman, Andac / Ergun, Tulin

    Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG

    2017  Volume 15, Issue 2, Page(s) 217–219

    Language English
    Publishing date 2017-02
    Publishing country Germany
    Document type Letter
    ZDB-ID 2093479-8
    ISSN 1610-0387 ; 1610-0379
    ISSN (online) 1610-0387
    ISSN 1610-0379
    DOI 10.1111/ddg.12956_g
    Database MEDical Literature Analysis and Retrieval System OnLINE

    Full text online

    More links

    Kategorien

    In stock of ZB MED Cologne/Königswinter

    Zs.A 6148: Show issues Location:
    Je nach Verfügbarkeit (siehe Angabe bei Bestand)
    bis Jg. 2021: Bestellungen von Artikeln über das Online-Bestellformular
    ab Jg. 2022: Lesesaal (EG)

    Order via subito

    This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.

  10. Article: Concurrence of Immune Thrombocytopenic Purpura and Alopecia Areata: A Rare Association.

    Salman, Andac / Eser, Ali

    International journal of trichology

    2016  Volume 8, Issue 1, Page(s) 52–53

    Language English
    Publishing date 2016-03-25
    Publishing country India
    Document type Journal Article
    ZDB-ID 2570982-3
    ISSN 0974-9241 ; 0974-7753
    ISSN (online) 0974-9241
    ISSN 0974-7753
    DOI 10.4103/0974-7753.179392
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

    Order via subito

    This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.

To top